Company Filing History:
Years Active: 2003-2005
Title: Innovative Contributions of Inventor Wai-Pan Chan in Enzyme Treatments
Introduction
Wai-Pan Chan is a notable inventor based in Castro Valley, California, known for his significant contributions to the field of biopharmaceuticals. With a total of three patents to his name, Chan's work primarily focuses on advancements in enzyme treatments, particularly related to metabolic disorders.
Latest Patents
One of Wai-Pan Chan's most recent patents addresses the creation of a highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase. This invention not only includes the enzyme itself but also biologically active mutants, fragments, and analogs thereof. Additionally, it encompasses pharmaceutical formulations intended for the treatment of diseases caused by deficiencies in this particular enzyme, such as MPS VI. The patent further outlines methods for producing and purifying the recombinant enzyme to achieve a highly purified form, which is crucial for effective treatment options. This innovative work marks a significant step forward in the biopharmaceutical sector, particularly for patients suffering from genetic disorders linked to enzyme deficiencies.
Career Highlights
Wai-Pan Chan is currently employed at BioMarin Pharmaceutical Inc., a company renowned for its dedication to developing innovative biopharmaceuticals. His role includes applying his expertise in enzyme research to facilitate the creation and enhancement of therapeutic solutions.
Collaborations
Throughout his career, Wai-Pan Chan has collaborated with talented colleagues including Minmin Qin and Lin Chen. Their combined efforts have been instrumental in advancing research and development initiatives within their field, ensuring that they remain at the forefront of enzyme therapy innovations.
Conclusion
Wai-Pan Chan exemplifies the spirit of innovation in the biopharmaceutical industry. His contributions, particularly in enzyme treatments, highlight the importance of research and collaboration in creating therapeutic avenues that can significantly improve the quality of life for individuals with metabolic disorders. As innovations continue to evolve, Chan's work will undoubtedly play a vital role in shaping the future of enzyme-based treatments.